Search
for
Sort by
Research 661–690 of 668
- The Role of Probiotics and Synbiotics on Hirsutism
- Therapeutic Effects of Natural Products on Human Diseases
- Association between the serum estrone-to-estradiol ratio and parameters related to glucose metabolism and insulin resistance in women with polycystic ovary syndrome
- Isoginkgetin, a natural biflavonoid from Ginkgo biloba, inhibits inflammatory response in endothelial cells via suppressing NF-κB activation
- Serum adiponectin level is negatively related to insulin resistance in women with polycystic ovary syndrome
- Green Nanodrugs: Research Progress and Challenges of Plant-Derived Nanovesicles in Tumor Treatment
- Polycystic ovary syndrome and psychological distress: Urban–rural comparison among reproductive-aged women in Bangladesh
- PROLACTIN AND HYPERPROLACTINAEMIA IN FEMALE REPRODUCTIVE ENDOCRINOLOGY – AN UPDATE
- Lipin 1 Gene Polymorphisms in Polycystic Ovary Syndrome
- Knowledge gaps and health practices related to polycystic ovary syndrome among women in Southwestern Saudi Arabia: a cross-sectional study
- Anabolic-Androgenic Steroids and Cardiometabolic Derangements
- Insulin resistance and β-cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome
- POLYCYSTIC OVARY SYNDROME: DIAGNOSTIC CRITERIA AND TREATMENT METHODS
- International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective
- Polycystic Ovary Syndrome (PCOS): A Concerning Hormonal Condition and its Bodily Impact on Women
- Congenital Adrenal Hyperplasia
- Cardiometabolic profile of young women with hypoprolactinemia
- Cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Polycystic Ovarian Syndrome: Exploring Hypertension and Cardiometabolic Implications
- Polycystic Ovary Syndrome: A Comprehensive Review of Its Clinical Presentation, Comorbidities, Long-Term Complications and Management
- Metabolic risk in PCOS: phenotype and adiposity impact
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Integrated Model of Care for Polycystic Ovary Syndrome
- Association of severity of menstrual dysfunction with cardiometabolic risk markers among women with polycystic ovary syndrome
- Interval training and cardiometabolic health in reproductive-aged females
- Cardiometabolic Risk Factors in Atorvastatin-Treated Women with Euthyroid Autoimmune Thyroiditis
- Beyond Counting Sheep: Exploring the Link between Polycystic Ovary Syndrome and Sleep Health